Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs12325863 | chr17:50263148 | A/C | 4.41E-5 | 174 | 25.6 | 28.38 | 14.43 | KM Plot |
PCPG | rs12327941 | chr2:176199918 | G/T | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |
PCPG | rs12328954 | chr2:24354147 | G/C | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs12329043 | chr2:24358160 | A/C | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs12329297 | chr2:24358001 | G/C | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs12346749 | chr9:36099880 | G/T | 0 | 177 | 25.47 | 26.05 | 2.93 | KM Plot |
PCPG | rs12365075 | chr11:2250672 | C/A | 0.000187 | 176 | 25.08 | 25.77 | 85.88 | KM Plot |
PCPG | rs12403768 | chr1:40505210 | G/T | 2.63E-6 | 174 | 25 | 24.23 | 37.18 | KM Plot |
PCPG | rs12408735 | chr1:40512261 | C/T | 3.3E-6 | 170 | 25 | 25.53 | 37.18 | KM Plot |
PCPG | rs12438427 | chr15:56295062 | A/T | 0.000407 | 178 | 21.55 | 25.7 | 25.2 | KM Plot |
PCPG | rs12443357 | chr15:56305980 | C/T | 0.000443 | 177 | 25 | 25.7 | 21.55 | KM Plot |
PCPG | rs12443539 | chr16:88642112 | G/A | 0.000211 | 172 | 25.4 | 24.35 | 14.47 | KM Plot |
PCPG | rs12447033 | chr16:71583655 | G/T | 0.000113 | 178 | 24.85 | 25.75 | 15.82 | KM Plot |
PCPG | rs12447979 | chr16:1688806 | T/A | 0 | 177 | 25 | 29.57 | 2.93 | KM Plot |
PCPG | rs12450602 | chr17:50300195 | C/G | 5.89E-5 | 178 | 25.53 | 28.3 | 14.47 | KM Plot |